Bolt Biotherapeutics, Inc. Common Stock (BOLT)

Typically moves ±3.81% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-11-12 APPROXIMATE

Across 21 earnings reports since May 13, 2021, Bolt Biotherapeutics, Inc. Common Stock (BOLT) has a clear post-earnings pattern. It moves ±3.81% on average after reporting and finishes higher 47.6% of the time. Its largest post-earnings gain was +13.12% (May 11, 2023) and its largest decline was -15.96% (Aug 11, 2026). The next earnings report is predicted for 2026-11-12 (approximate).

Earnings reactions

How BOLT moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±3.81%

Positive %

47.6%

Negative %

52.4%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 11, 2026	☽ POST	-15.96%	open_in_new
May 12, 2026	☽ POST	-0.53%	open_in_new
Mar 12, 2026	☽ POST	+0%	open_in_new
Nov 12, 2025	☽ POST	+0%	open_in_new
Aug 14, 2025	☽ POST	-5.66%	open_in_new
May 12, 2025	☽ POST	-4.19%	open_in_new
Mar 24, 2025	☽ POST	+4.64%	open_in_new
Nov 12, 2024	☽ POST	+0.37%	open_in_new
Aug 13, 2024	☽ POST	-2.23%	open_in_new
Mar 21, 2024	☽ POST	+0%	open_in_new
Nov 09, 2023	☽ POST	-2.98%	open_in_new
Aug 07, 2023	☽ POST	-0.38%	open_in_new
May 11, 2023	☽ POST	+13.12%	open_in_new
Mar 29, 2023	☽ POST	+3.85%	open_in_new
Nov 10, 2022	☽ POST	+2.33%	open_in_new
Aug 10, 2022	☽ POST	-7.87%	open_in_new
May 12, 2022	☽ POST	-1.94%	open_in_new
Mar 30, 2022	☽ POST	-1.44%	open_in_new
Nov 09, 2021	☽ POST	-4.44%	open_in_new
Aug 12, 2021	☽ POST	+5.72%	open_in_new
May 13, 2021	☽ POST	+2.43%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±3.81%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 8 →

Funds holding

$184664

Total value held

Flat

2 added · 2 reduced

Pfizer Inc

$133832 Held

Blackrock, Inc.

$37388 Held

Morgan Stanley

$12108 -1.38%

Ubs Group Ag

$982 NEW BUY

Jpmorgan Chase & Co

$165 Held

SEC Filing Types

description SCHEDULE 13G

1 chevron_right

Recent SEC Filings

9 most recent

Form	Date Filed	View on EDGAR
SCHEDULE 13G	20260813	open_in_new SEC.gov
10-Q	20260811	open_in_new SEC.gov
8-K	20260811	open_in_new SEC.gov
4	20260611	open_in_new SEC.gov
4	20260611	open_in_new SEC.gov
4	20260611	open_in_new SEC.gov
4	20260611	open_in_new SEC.gov
4	20260611	open_in_new SEC.gov
8-K	20260611	open_in_new SEC.gov

Frequently asked about BOLT earnings

When does Bolt Biotherapeutics, Inc. Common Stock report earnings next? expand_more

Bolt Biotherapeutics, Inc. Common Stock (BOLT)'s next earnings date is approximate for 2026-11-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does BOLT stock move after earnings? expand_more

Over 21 reports, BOLT has moved an average of ±3.81% the session after earnings, closing higher 47.6% of the time.

What was BOLT's biggest post-earnings move? expand_more

BOLT's largest post-earnings gain on record was +13.12% on May 11, 2023, and its largest decline was -15.96% on Aug 11, 2026.

Where can I find Bolt Biotherapeutics, Inc. Common Stock's SEC filings? expand_more

All of Bolt Biotherapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.